retatrutide vs TRIUMPH — genuinely asking which matters more
Long-ish post, sorry. tl;dr at the bottom. I have been tracking retatrutide against triglycerides for 35 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here. Caveats up front: one person, one…
the glucagon component changes the side effect profile, not just the efficacy
the glucagon component changes the side effect profile, not just the efficacy
Yes, exactly this, and it is the bit that took me 70 weeks to accept.
TRIUMPH data is phase 2, not phase 3, smaller n and shorter
Research use material only, no human-use approval anywhere. Posts must describe what happened, not instruct strangers.
This is correct. Triple agonism is genuinely different.
Respectfully this is a sample of one presented as a finding.
TRIUMPH data is phase 2, not phase 3, smaller n and shorter
That is net peptide content, not purity. Different number, different meaning.
triple agonism plus glucagon is a different physiological state than GIP/GLP-1 dual